AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

People with extensive-stage small cell lung cancer in England and [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

Protara Therapeutics has reported updated 12-month data from its ongoing [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]